Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Keith Bible
Mayo Clinic Cancer Center P2C
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chinese University of Hong Kong-Prince of Wales Hospital
Shatin, Hong Kong
- National University Hospital Singapore
Singapore, Singapore
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro-Minnesota Nci Community Oncology Research Program
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 21 Sept 2017
- Registered enrollment
- 7
- Registry id
- NCT01340794
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.